Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MRNA-seq of HCC1954 siControl and siRNF40

ABSTRACT: mRNA-seq of HCC1954 siControl and siRNF40

PROVIDER: PRJEB38971 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR4277240.fastq.gz	Fastqsanger.gz
	ERR4277250.fastq.gz	Fastqsanger.gz
	ERR4277241.fastq.gz	Fastqsanger.gz
	ERR4277251.fastq.gz	Fastqsanger.gz
	ERR4277242.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 15

Similar Datasets

mRNA-seq of HCC1954 siControl and siUSP22

Project description:mRNA-seq of HCC1954 siControl and siUSP22

| PRJEB34048 | ENA

mRNA-seq of HCC1954 siControl and siUSP22

Project description:The analysis of genes affected upon USP22 kcnockdown in HCC1954 cells

2020-08-31 | E-MTAB-8256 | biostudies-arrayexpress

mRNA-seq of HCC1954 siControl and siRNF40

Project description:The analysis of genes affected upon RNF40 knockdown in HCC1954 cells

2020-11-16 | E-MTAB-9234 | biostudies-arrayexpress

mRNA-seq of HCC1806 cells, treated with siControl or siRNF40 for 48 hours

Project description:mRNA-seq of HCC1806 cells, treated with siControl or siRNF40 for 48 hours

| PRJEB53816 | ENA

Transcriptomic and Epigenetic analysis of cell line derivatives from H2087 and HCC1954 cell lines

Project description:We profiled the transcriptomes of latency-competent cells derived from the human cancer cell lines H2087 (lung adenocarcinoma) and HCC1954 (breast adenocarcinoma) in mitogen-rich and mitogen-low media (MRM and MLM, respectively). In addition, we analyzed the epigenetic landscape of these cell lines under MLM conditions. H2087 and HCC1954 parental and latency-competent cell derivatives (LCCs) were grown for 48hr in mitogen-rich or mitogen-low conditions in vitro, and whole RNA was extracted for RNA-seq profiling. Cell lines were also grown in MLM conditions and DNA extracted for ChIP-Seq experiments.

2016-03-29 | E-GEOD-72956 | biostudies-arrayexpress

Hepatocellular carcinoma Huh7: siHINT1 vs. siControl

Project description:LncRNA and mRNA expression profiling of Hepatocellular carcinoma Huh7 when HINT1 knockdown. HINT1 is a novel tumor suppressor gene, which can regulate the transcription of a variety of cancer-related genes, and its regulation networks is poorly understood in hepatocellular carcinoma. We used the total RNA from siControl and siHINT1 Huh7 cells to analyze the differentially expressed lncRNA and mRNA which were regulated by HINT1, and further explored the ceRNA network that HINT1 may involved.

2022-03-09 | GSE177624 | GEO

mRNA-seq

Project description:mRNA-seq

2021-10-06 | OEX00010594 | NODE

Expression data from HCC1954 cells treated with DMSO, Melatonin (mela), Lapatinib (lapa) and their combination(m_l)

Project description:Drug treatment-induced transcriptional changes in HCC1954 cells.

2021-11-30 | GSE175906 | GEO

PC-3 cells: siControl vs. siRNA ARHGAP21

Project description:Transcriptional profiling of the prostate adenocarcinoma cell line PC-3 comparing control cells transfected with a pool of oligonucleotides control (siControl) with cells transfected a pool of oligonucleotides specific to inhibit ARHGAP21 expression (siARHGAP21). The efficiency of the transfection was checked with quantitative PCR and western blotting. Goal was to determine the effects of ARHGAP21 silencing on global PC-3 gene expression. Two-condition experiment, siControl vs. siARHGAP21 PC-3 cells with three biological samples of PC3 cells transfected with a pool of oligonucleotides control (siControl 1, 2 and 3) and three biological samples of PC3 cells transfected with a pool of oligonucleotides specific to inhibit ARHGAP21 (siARHGAP21 1, 2 and 3). For each sample (three siControl and three siARHGAP21), two technical replicates were performed (labelled with Cy3 or Cy5).

2012-12-31 | E-GEOD-37888 | biostudies-arrayexpress

Hepatocellular carcinoma Huh7: siHINT1 vs. siControl

Project description:Hepatocellular carcinoma Huh7: siHINT1 vs. siControl

| PRJNA737130 | ENA